Stereotactic Body Radiation Therapy (SBRT) for prostate cancer: Preliminary results of toxicity

This article was originally published here

Arch Ital Urol Androl. 2021 Oct 4;93(3):370-372. doi: 10.4081/aiua.2021.3.370.


To the Editor, Prostate cancer is the second most common cancer in men in Morocco after lung cancer. External radiotherapy (RTE) is a curative therapeutic option for localized prostate cancer, However the conventional RTE remains a long treatment (7- 8 weeks, 5 days a week) which is demanding for patients and make difficult to manage the waiting lists. The development of imaging and irradiation techniques over the last decades has allowed a high precision in the delivery of the dose to the target organ and a better protection of the organs at risk (OAR), which has encouraged the hypo fractionated irradiation of localized prostate cancer, especially after the results of radiobiology studies that suggested a low report a/b for the prostate.

PMID:34839647 | DOI:10.4081/aiua.2021.3.370